MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Local Field Potentials (LFP) Insights in the Treatment of X-linked Dystonia-Parkinsonism with Deep Brain Stimulation of the Subthalamic Nucleus

    J. Chen, W. Tse (New York, USA)

    Objective: To demonstrate sustained improvement in parkinsonism and dystonia in patients with X-linked Dystonia-Parkinsonism (XDP) after deep brain stimulation (DBS) of the subthalamic nucleus (STN)…
  • 2026 International Congress

    Evaluating the Stability of a Short Smell Test in the PREDICT-PD Cohort

    S. Meyer, A. Kuri, J. Bestwick, S. Waters, H. Chohan, A. Shahid, L. Smith, C. Simonet, L. Pérez-Carbonell, E. de Pablo-Fernandez, A. Schrag, A. Noyce (London, United Kingdom)

    Objective: To evaluate the stability of a 6-item smell test, in the context of a prodromal Parkinson’s (PD) cohort. Background: Short smell tests have been…
  • 2026 International Congress

    The Nature of autonomic dysfunction and its relationship with motor symptoms in Drug-Naive Parkinson’s Disease Patients: Korean Cohort Data

    YS. Hwang, J. Park, JM. Seok (Jeonju, Republic of Korea)

    Objective: We aimed to characterize the domain-specific distribution of autonomic symptoms in newly diagnosed, drug-naive PD and to investigate whether distinct autonomic patterns are associated…
  • 2026 International Congress

    Distinct FDG PET Metabolic Signatures and Dopaminergic Loss Across Multiple System Atrophy Subtypes

    T. Carther-Krone, J. Perron, CS. Lee, JH. Ko (Winnipeg, Canada)

    Objective: To delineate subtype‑specific metabolic networks in Multiple system atrophy (MSA) using FDG‑PET, and to examine how these patterns relate to striatal dopamine transporter (DAT)…
  • 2026 International Congress

    Phenoconversion from Rapid Eye Movement Sleep Behavior Disorder to Parkinson’s Disease: A multimodal Imaging Study

    J. Ebina, K. Kamiya, M. Hori, M. Shibukawa, J. Nagasawa, T. Hirayama, S. Mizumura, O. Kano (Tokyo, Japan)

    Objective: To elucidate the pathological progression from rapid eye movement sleep behavior disorder (RBD) to Parkinson’s disease (PD), we investigated tissue-level neurodegenerative changes using multimodal…
  • 2026 International Congress

    Exchangeable copper as a monitoring tool in Wilson disease: lessons from a 24-month prospective cohort

    C. Desjardins, N. Djebrani-Oussedik, M. Obadia, D. Rahli, D. Debray, A. Poujois (Paris, France)

    Objective: To evaluate exchangeable copper (CuEXC) longitudinal kinetics and its association with clinical outcomes at 24 months in Wilson disease (WD). Background: CuEXC, reflecting the…
  • 2026 International Congress

    Real-World Clinical Outcomes of Adaptive versus Continuous Deep Brain Stimulation in Early-Stage Parkinson’s Disease: A Systematic Review and Meta-Analysis of 2024-2025 Trials

    F. Al-Zaidi (Almaty, Kazakhstan)

    Objective: To evaluate the comparative efficacy, safety, and energy efficiency of adaptive deep brain stimulation (aDBS) versus continuous deep brain stimulation (cDBS) in Parkinson’s disease…
  • 2026 International Congress

    Effects of Dance for Parkinson’s on Disease Severity, Functional Mobility, and Habitual Physical Activity: A Feasibility Study

    N. Kalyani, K. Sullivan, G. Moyle, S. Brauer, ER. Jeffrey, G. Kerr (Toowoomba, Australia)

    Objective: To examine the feasibility and effects of a Dance for Parkinson’s Disease® (DfPD®) intervention on disease severity, functional mobility, fine manual dexterity, and habitual…
  • 2026 International Congress

    Clinical Outcomes and Safety of Ablative Surgery for Parkinson’s Disease in Resource-Limited Settings: A Cohort from Indonesia

    R. Ibonita, A. Sulistyanto, N. Adhitama, R. Puspa, A. Devicaesaria, M. Wedariani, S. Lumempouw (East Jakarta, Indonesia)

    Objective: To evaluate the clinical outcomes and safety of ablative surgery for Parkinson’s disease at Indonesia’s national tertiary referral neurological center. Background: Deep brain stimulation…
  • 2026 International Congress

    Considering Oral Health to Optimise the Potential for Current and Future Treatments in Parkinson’s Disease

    J. Price, H. Martin (Powys, United Kingdom)

    Objective: To determine if the Oral Health Assessment Questionnaire (OHAQ) devised by 2 Parkinson’s Disease Nurse Advanced Practitioners (PDNAP) could facilitate a healthier mouth to…
  • « Previous Page
  • 1
  • …
  • 128
  • 129
  • 130
  • 131
  • 132
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley